Claudia Zamaly Ferreira Hernández

Claudia Zamaly Ferreira Hernández

Auto-generated profile, based on publicly available information

Claudia Zamaly Ferreira Hernández

Hospital de Alta Especialidad Bicentenario de la Independencia Universidad Autonoma de Guadalajara Servicios Médicos Integrales Populares Fundación Universitaria Sanitas Pontificia Universidad Javeriana Pontificia Universidad Católica del Ecuador Instituto de Educación Capacitación y Certificación de México

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2025 in International Science Journal
Verified
Journal Article
Closed access
CVCarolina Paola Ortiz Valdés
Carolina Paola Ortiz Valdés
XAXóchitl Monteon Aspeitia
Xóchitl Monteon Aspeitia
HMHillary Yahiry Mejía Montiel
Hillary Yahiry Mejía Montiel
SPSilvana Cabrera Puentes
Silvana Cabrera Puentes
CHClaudia Zamaly Ferreira Hernández
Claudia Zamaly Ferreira Hernández
ACAndrea Cristina Naranjo Calvachi
Andrea Cristina Naranjo Calvachi
Inflammatory skin diseases are increasingly understood through the lens of the cutaneous microbiome, a dynamic ecosystem whose interactions with the host shape immune responses, barrier integrity, and clinical disease expression. This review synthesizes evidence from two decades of research to examine how microbial composition, functional dysbiosis, and host–microbe crosstalk contribute to the pathophysiology of atopic dermatitis, psoriasis, acne, rosacea, and Malassezia-associated dermatoses. The findings demonstrate that innate immune mechanisms—particularly barrier components, antimicrobial peptides, and pattern recognition receptors—form the primary interface between the microbiome and the host, while disease-specific adaptive pathways (Th2 in atopic dermatitis, Th17 in psoriasis) define distinct inflammatory phenotypes. Temporal trends reveal a rapid expansion of microbiome research beginning in the late 2010s, driven by advances in sequencing and molecular immunology, while thematic analysis highlights an imbalance between mechanistic studies and the still limited development of microbiome-based therapies. The review also identifies a critical gap concerning the underrepresentation of diverse populations, especially in regions such as Mexico, Colombia, and Ecuador, where environmental and cultural factors significantly influence microbial ecology. Collectively, the evidence underscores the microbiome’s central role in shaping cutaneous inflammation and emphasizes the need for geographically inclusive research and translational innovation to support future dermatologic practice.

12 December 2025 in IECCMEXICO
Verified
Journal Article
Closed access
AHAndres Felipe Herrera Homez
Andres Felipe Herrera Homez
HMHillary Yahiry Mejía Montiel
Hillary Yahiry Mejía Montiel
MGMaría Camila Fontecha Garzón
María Camila Fontecha Garzón
YAYoleimys Lizeth Fuentes Araujo
Yoleimys Lizeth Fuentes Araujo
MTMaría Fernanda Banderas Torres
María Fernanda Banderas Torres
CHClaudia Zamaly Ferreira Hernández
Claudia Zamaly Ferreira Hernández
Cutaneous immunity operates through a complex integration of structural, microbial, cellular, and neuroimmune mechanisms that collectively determine the skin’s ability to maintain homeostasis and respond to injury or inflammation. This review synthesizes contemporary evidence on epidermal barrier dysfunction, microbiome dysbiosis, antigen-presenting cell networks, tissue-resident memory T cells, and neuroimmune signaling to construct a comprehensive model explaining the pathophysiology of major inflammatory dermatoses, including atopic dermatitis, psoriasis, and allergic contact dermatitis. Key findings highlight barrier impairment as an initiating factor in immune activation, microbial imbalance—particularly Staphylococcus aureus overgrowth—as a powerful amplifier of inflammatory responses, and specialized immune circuits as central drivers of chronicity. Neuroimmune interactions, although less frequently explored, emerge as critical contributors to persistent pruritus and symptom exacerbation. The integration of these mechanisms provides a unified framework that enhances understanding of disease heterogeneity and supports the development of targeted, context-specific approaches relevant to diverse populations such as those in Mexico, Colombia, and Ecuador. This multidimensional perspective reaffirms the skin as a fully active immune organ and underscores the value of coordinated strategies that address structural integrity, microbial ecology, immune regulation, and neural pathways.